Alector (ALEC) Invested Capital (2018 - 2026)
Alector (ALEC) reported Invested Capital of $11.9 million for Q1 2026, down 87.46% year-over-year from $94.6 million in Q1 2025, and down 61.75% on a QoQ basis from $31.0 million in Q4 2025.
Alector (ALEC) has 9 years of Invested Capital data on file, last reported at $11.9 million in Q1 2026.
- Quarterly Invested Capital fell 87.46% year-over-year to $11.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.9 million (down 87.46% YoY) and the FY2025 annual result came in at $31.0 million, down 75.54% from the prior year.
- Invested Capital slipped to $11.9 million in Q1 2026 per ALEC's latest filing, from $31.0 million in the prior quarter.
- Across five years, Invested Capital topped out at $288.5 million in Q2 2022 and bottomed at $11.9 million in Q1 2026.
- The 5-year median for Invested Capital is $150.6 million (2024), against an average of $149.5 million.
- The widest annual swing landed in 2022, when Invested Capital soared 56.36%; it then plunged 87.46% in 2026.
- Tracing ALEC's Invested Capital over 5 years: stood at $214.4 million in 2022, then plunged by 37.44% to $134.2 million in 2023, then fell by 5.48% to $126.8 million in 2024, then tumbled by 75.54% to $31.0 million in 2025, then slumped by 61.75% to $11.9 million in 2026.
- Per Business Quant, the three latest ALEC Invested Capital figures stand at $11.9 million (Q1 2026), $31.0 million (Q4 2025), and $57.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Alector | 238.87 Mn | 32.36 Mn | - | 11.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.86 Mn |
| Dec 31, 2025 | 31.02 Mn |
| Sep 30, 2025 | 57.71 Mn |
| Jun 30, 2025 | 71.18 Mn |
| Mar 31, 2025 | 94.61 Mn |
| Dec 31, 2024 | 126.80 Mn |
| Sep 30, 2024 | 118.93 Mn |
| Jun 30, 2024 | 150.57 Mn |
| Mar 31, 2024 | 178.91 Mn |
| Dec 31, 2023 | 134.16 Mn |
| Sep 30, 2023 | 162.56 Mn |
| Jun 30, 2023 | 196.31 Mn |
| Mar 31, 2023 | 183.02 Mn |
| Dec 31, 2022 | 214.44 Mn |
| Sep 30, 2022 | 253.10 Mn |
| Jun 30, 2022 | 288.52 Mn |
| Mar 31, 2022 | 267.54 Mn |
| Dec 31, 2021 | 300.72 Mn |
| Sep 30, 2021 | 335.89 Mn |
| Jun 30, 2021 | 184.52 Mn |
| Mar 31, 2021 | 227.83 Mn |
| Dec 31, 2020 | 267.53 Mn |
| Sep 30, 2020 | 310.19 Mn |
| Jun 30, 2020 | 355.33 Mn |
| Mar 31, 2020 | 391.73 Mn |
| Dec 31, 2019 | 194.74 Mn |
| Sep 30, 2019 | 218.59 Mn |
| Jun 30, 2019 | 245.72 Mn |
| Mar 31, 2019 | 266.19 Mn |
| Dec 31, 2018 | -97.40 Mn |
| Sep 30, 2018 | -82.78 Mn |
| Jun 30, 2018 | -69.40 Mn |
| Mar 31, 2018 | -59.50 Mn |